Evidence map›Paper›PMID 34204743›Full record

ArticleJournal of clinical medicine2021

Incidence and Risk Factors for Acute Kidney Injury during the Treatment of Methicillin-Sensitive

Romain Crochette, Camille Ravaiau, Lucia Perez, Jean-Philippe Coindre, Giorgina Barbara Piccoli, Sophie Blanchi

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Cefazolin Versus Flucloxacillin for Methicillin-SusceptibleAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Romain CrochetteDepartment of Nephrology, Le Mans General Hospital, 72000 Le Mans, France.ORCID 0000-0001-5826-0655
Camille RavaiauDepartment of Nephrology, Le Mans General Hospital, 72000 Le Mans, France.
Lucia PerezDepartment of Infectious Diseases, Le Mans General Hospital, 72000 Le Mans, France.
Jean-Philippe CoindreDepartment of Nephrology, Le Mans General Hospital, 72000 Le Mans, France.
Giorgina Barbara PiccoliDepartment of Nephrology, Le Mans General Hospital, 72000 Le Mans, France.
Sophie BlanchiDepartment of Infectious Diseases, Le Mans General Hospital, 72000 Le Mans, France.
Centre Hospitalier du Mans · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCloxacillin has been associated with the occurrence of acute kidney injury (AKI). The incidence of this complication in the literature is low (2.5-3.5%) and probably underestimated, since most studies were done by selecting the presence of AKI in discharge codes.

objectivesThe primary goal was to define the incidence of AKI in patients with a methicillin-sensitive PATIENTS AND

methodsWe carried out a retrospective study. The inclusion criteria were adult patients hospitalized in a medical department at the Le Mans Hospital between 1 July 2012 and 1 July 2019 with a diagnosis of methicillin-sensitive

resultsOne hundred twenty-three patients were included in the study. Forty-two patients (34.2%) developed AKI. In the multivariate analysis, age, the use of diuretics and the presence of endocarditis were independently associated with AKI. Age was associated with an OR of 4.38 (

conclusionsThe occurrence of AKI is frequent during cloxacillin based antibiotic regimens for methicillin-sensitive

Indexed as

acute kidney injurycloxacillindiureticsendocarditisStaphylococcus infection

Identifiers

PMID34204743
PMCPMC8231553
OpenAlexW3168859109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.